C Baues
Overview
Explore the profile of C Baues including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brockelmann P, Muller H, Fuchs M, Gillessen S, Eichenauer D, Borchmann S, et al.
Ann Oncol
. 2024 Dec;
PMID: 39706337
Background: This study aimed to evaluate the correlation between progression-free (PFS) and overall survival (OS) after first-line treatment of classical Hodgkin lymphoma (HL) and to assess the potential of PFS...
2.
Ferdinandus J, Muller H, Damaschin C, Jacob A, Meissner J, Krasniqi F, et al.
Ann Oncol
. 2023 Dec;
35(3):276-284.
PMID: 38061428
Background: Persisting cancer-related fatigue impairs health-related quality of life (HRQoL) and social reintegration in patients with Hodgkin's lymphoma (HL). The GHSG HD18 trial established treatment de-escalation for advanced-stage HL guided...
3.
Ostheimer C, Maurer M, Ebert N, Schmitt D, Krug D, Baumann R, et al.
Strahlenther Onkol
. 2021 Mar;
197(6):560-561.
PMID: 33674905
No abstract available.
4.
Eichenauer D, Kreissl S, Buhnen I, Baues C, Kobe C, van Heek L, et al.
Ann Oncol
. 2021 Mar;
32(6):807-810.
PMID: 33667668
No abstract available.
5.
Ostheimer C, Maurer M, Ebert N, Schmitt D, Krug D, Baumann R, et al.
Strahlenther Onkol
. 2021 Jan;
197(5):385-395.
PMID: 33410959
Background: In radical radiochemotherapy (RCT) of inoperable non-small-cell lung cancer (NSCLC) typical prognostic factors include T- and N-stage, while there are still conflicting data on the prognostic relevance of gross...
6.
Oertel M, Elsayad K, Engenhart-Cabillic R, Reinartz G, Baues C, Schmidberger H, et al.
Strahlenther Onkol
. 2020 Oct;
196(12):1096-1102.
PMID: 33125504
Purpose: The coronavirus pandemic is affecting global health systems, endangering daily patient care. Hemato-oncological patients are particularly vulnerable to infection, requiring decisive recommendations on treatment and triage. The aim of...
7.
Stippel D, Wahba R, Bruns C, Bunck A, Baues C, Persigehl T
Chirurg
. 2018 Jul;
89(11):872-879.
PMID: 30030546
Background: The incidence of primary liver tumors is rising. Modern minimally invasive, image-guided procedures offer a potentially curative therapy option. Objective: The aim of this study was to evaluate the...
8.
Voltin C, Goergen H, Baues C, Fuchs M, Mettler J, Kreissl S, et al.
Ann Oncol
. 2018 Jul;
29(9):1926-1931.
PMID: 30010775
Background: Bone marrow (BM) involvement defines advanced-stage Hodgkin lymphoma and thus has impact on the assignment to treatment. Our aim was to evaluate whether the established BM biopsy may be...
9.
Baues C, Semrau R, Gaipl U, Brockelmann P, Rosenbrock J, Engert A, et al.
Strahlenther Onkol
. 2016 Oct;
193(2):95-99.
PMID: 27704149
Background: Patients with classical Hodgkin's lymphoma (cHL) have a good prognosis even in advanced stages. However, combined chemo- and radiotherapy, as the standard of care, is also associated with treatment-related...
10.
Kriz J, Baues C, Engenhart-Cabillic R, Haverkamp U, Herfarth K, Lukas P, et al.
Strahlenther Onkol
. 2016 Sep;
193(2):100-108.
PMID: 27678010
Introduction: Field design changed substantially from extended-field RT (EF-RT) to involved-field RT (IF-RT) and now to involved-node RT (IN-RT) and involved-site RT (IS-RT) as well as treatment techniques in radiotherapy...